1. Market Research
  2. > Healthcare
  3. > Medical Supply Market Trends
South and Central America Cell Therapy Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Therapy Type ; Product ; Technology ; Application ; End User and Country

South and Central America Cell Therapy Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Therapy Type ; Product ; Technology ; Application ; End User and Country

  • February 2021
  • 123 pages
  • ID: 6027867
  • Format: PDF
  • The Insight Partners


Table of Contents

Search Inside

The South and Central America cell therapy market is expected to reach US$ 415.8 million by 2027 from US$ 271.9 million in 2019; it is anticipated to grow at a CAGR of 5.5 % during 2019-2027.
The South and Central America cell therapy market is growing primarily due to increasing prevalence of chronic diseases, rising adoption of regenerative medicines, and growing number of approvals for cell-based therapies. Factors such as high cost of cell therapy manufacturing restraining the growth of the market.
Mainly stem cells are used for cell therapies because of their ability to differentiate specific cells required for repairing damaged or defective tissues or cells.Moreover, cell therapy also has applications in the development of regenerative medicines.

The Middle East & Africa is hindered due to the burden of chronic diseases owing to the lack of proper healthcare system across the region and low awareness about the novel therapeutics available in the market.The prevalence of cancer in South and Central America is constantly increasing.

According to the American Cancer Society report 2018, around 1.3 million new cancer cases and 666,000 cancer deaths occurred in Latin America and the Caribbean. Moreover, according to the same source, out of all the cancer cases, the number of prostate, breast, and colorectal cancer cases is high in the Latin America and Caribbean region.
According to National Cancer Institute (INCA) estimates, Brazil reports about 393,000 new cases of cancer per year.According to the World Health Organization’s (WHO) report published in May 2019, around 559,371 cases of cancer were observed in Brazil in 2018, out of which, 278,607 males and 280,764 females were suffering from cancer.

Moreover, according to the same source, in 2018, about 85,620 cases of breast cancer were diagnosed in Brazil, which was the highest among all types of cancer cases recorded in the country. In 2018, WHO also reported that out of 1.3 million deaths in Brazil, around 74% were due to noncommunicable diseases (NCDs), which include cardiovascular disease, diabetes, cancer, and chronic lung diseases. Many of these chronic conditions can be treated with cell therapies, which would increase the demand for cell therapies in the coming years.
The COVID-19 pandemic has become the most significant challenge across South and Central America.Countries such as Brazil and Argentina have also registered a significant number of positive patients.

As per Worldometers, in Brazil, the number of cases increased to about 8.82 million, with 216,000 deaths till date (January 21st 2021). With the second wave of the COVID-19 outbreak, there has been an increasing number of cases in Latin America. Currently, the Brazil is rapidly increasing its clinical programs to fight against the outbreak. There has been a rising focus on cell and gene therapies to treat COVID-19 effectively. For instance, Brazilian Association of Hematology, Hemotherapy and Cellular Therapy have constituted a panel of experts to carefully examine and review the use of cell therapies for the treatment of COVID 19.
In 2019, the allogeneic segment accounted for a larger share of the South and Central America cell therapy market.The growth of the market for this segment is attributed to the factors such as increasing number of product launch to accelerate the overall product availability for stem therapy using allogeneic stem cell therapeutics.

However, the autologous segment is likely to register a higher CAGR in the market during the forecast period.
A few of the significant secondary sources referred to while preparing the report on the South and Central America cell therapy market are the World Health Organization (WHO), Food and Drug Administration (FDA), Centers of Disease Control and Prevention (CDC), American Cancer Society, and Brazil National Health Surveillance Agency or ANVISA, and Brazilian Association of Hematology, Hemotherapy and Cellular Therapy.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

ReportLinker may already be registered as a supplier with your company. If you want to Order by PO, check with us first and we'll let you know if we are a registered supplier and what the vendor number is. Otherwise, we'll provide you with the necessary information to register ReportLinker as a vendor.

Ahmad helps you find the right report:

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at [email protected] to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - [email protected] or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers

Asia Pacific Electric Beds Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Product ; Application ; End User and Country

  • $ 3000
  • February 2021
  • 82 pages

The Asia Pacific electric bed market is expected to reach US$ 1,027.55 million by 2027 from US$ 446.36 million in 2019; it is estimated to grow at a CAGR of 10.4% from 2020 to 2027. The growth of the Asia ...

  • APAC
  • Hospital Bed
  • Industry analysis
  • Hospital Beds Number
  • Chronic Disease Prevalence


Reportlinker.com © Copyright 2021. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on